Josef Leebmann

949 total citations
7 papers, 518 citations indexed

About

Josef Leebmann is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Josef Leebmann has authored 7 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Economics and Econometrics. Recurrent topics in Josef Leebmann's work include Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Josef Leebmann is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Josef Leebmann collaborates with scholars based in Germany, United States and Japan. Josef Leebmann's co-authors include Reinhard Klingel, Franz Heigl, Andreas Heibges, Ulrich Julius, E. Roeseler, Dennis Heutling, Winfried Maerz, Walter Lehmacher, Bernd Schmaußer and Anna‐Friederike Marx and has published in prestigious journals such as Circulation, European Heart Journal and Atherosclerosis.

In The Last Decade

Josef Leebmann

5 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Josef Leebmann Germany	5	403	112	111	101	101	7	518
Jingjing Schneider United States	7	355 0.9×	85 0.8×	75 0.7×	79 0.8×	139 1.4×	13	478
Julie Huang United States	10	160 0.4×	29 0.3×	73 0.7×	28 0.3×	85 0.8×	19	435
O. Afanasieva Russia	15	459 1.1×	141 1.3×	230 2.1×	96 1.0×	54 0.5×	82	622
Stefano Rota Italy	9	95 0.2×	51 0.5×	33 0.3×	33 0.3×	21 0.2×	10	419
C. Keller Germany	14	467 1.2×	56 0.5×	406 3.7×	182 1.8×	11 0.1×	34	862
Tadanobu Kuribayashi Japan	10	138 0.3×	50 0.4×	20 0.2×	146 1.4×	27 0.3×	24	425
Pum Joon Kim South Korea	15	505 1.3×	40 0.4×	535 4.8×	65 0.6×	11 0.1×	44	900
E. Roeseler Germany	9	540 1.3×	91 0.8×	235 2.1×	168 1.7×	117 1.2×	14	603
Francis Donaldson United Kingdom	8	46 0.1×	115 1.0×	59 0.5×	19 0.2×	11 0.1×	10	529
Alex Chase United Kingdom	6	203 0.5×	49 0.4×	138 1.2×	23 0.2×	14 0.1×	10	489

Countries citing papers authored by Josef Leebmann

Since Specialization

Citations

This map shows the geographic impact of Josef Leebmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Leebmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Leebmann more than expected).

Fields of papers citing papers by Josef Leebmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josef Leebmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Leebmann. The network helps show where Josef Leebmann may publish in the future.

Co-authorship network of co-authors of Josef Leebmann

This figure shows the co-authorship network connecting the top 25 collaborators of Josef Leebmann. A scholar is included among the top collaborators of Josef Leebmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josef Leebmann. Josef Leebmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Klingel, Reinhard, Wanja M. Bernhardt, Franz Heigl, et al.. (2025). Lipoprotein apheresis for lipoprotein(a)-associated progressive atherosclerotic cardiovascular disease: 12-years follow-up. Atherosclerosis. 410. 120508–120508.

2.

Julius, Ulrich, Franz Heigl, Volker Schettler, et al.. (2019). Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis. Journal of Clinical Apheresis. 34(4). 423–433. 14 indexed citations

3.

Moriarty, Patrick M., Klaus G. Parhofer, Stephan P. Babirak, et al.. (2016). Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial. European Heart Journal. 37(48). 3588–3595. 135 indexed citations

4.

Leebmann, Josef. (2014). Lipoproteinapherese – Wie sieht die Praxis aus?. Dialyse aktuell. 17(10). 535–539.

5.

Leebmann, Josef, E. Roeseler, Ulrich Julius, et al.. (2013). Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease. Circulation. 128(24). 2567–2576. 232 indexed citations

6.

Galldiks, Norbert, Lothar Burghaus, Christian Dohmen, et al.. (2011). Immunoadsorption in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Unsatisfactory Response to First-Line Treatment. European Neurology. 66(4). 183–189. 30 indexed citations

7.

Greiner, Andreas, Anna‐Friederike Marx, J Heesemann, et al.. (1994). Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis.. PubMed. 70(4). 572–8. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact